{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:40:05Z","timestamp":1793032805140,"version":"4.5.0"},"reference-count":253,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00203-026-05118-8","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:38:12Z","timestamp":1785908292000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CRISPR\/Cas system as a novel therapeutic strategy to combat multi-drug-resistant bacteria"],"prefix":"10.1007","volume":"208","author":[{"given":"Akmal","family":"Zubair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Abu Kawsar Prodhan","family":"Hemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaeldeen","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naila","family":"Afghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"5118_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2147\/IDR.S228089","volume":"13","author":"SN Abdi","year":"2020","unstructured":"Abdi SN et al (2020) Acinetobacter baumannii efflux pumps and antibiotic resistance. Infect Drug Resist 13:423\u2013434","journal-title":"Infect Drug Resist"},{"issue":"6","key":"5118_CR51","doi-asserted-by":"publisher","first-page":"100971","DOI":"10.1016\/j.disamonth.2020.100971","volume":"66","author":"MA Abushaheen","year":"2020","unstructured":"Abushaheen MA et al (2020) Antimicrobial resistance, mechanisms and its clinical significance. Dis Mon 66(6):100971","journal-title":"Dis Mon"},{"issue":"1","key":"5118_CR60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40816-021-00258-4","volume":"7","author":"AO Adeeyo","year":"2021","unstructured":"Adeeyo AO et al (2021) Plant active products and emerging interventions in water potabilisation: disinfection and multi-drug resistant pathogen treatment. Clin Phytoscience 7(1):31","journal-title":"Clin Phytoscience"},{"key":"5118_CR226","doi-asserted-by":"crossref","unstructured":"Adli M (2018) The CRISPR tool kit for genome editing and beyond. Nat Commun 9(1):1911","DOI":"10.1038\/s41467-018-04252-2"},{"key":"5118_CR166","doi-asserted-by":"crossref","unstructured":"Dela Ahator S et al (2022) The virulence factor regulator and quorum sensing regulate the type I-F CRISPR-Cas mediated horizontal gene transfer in Pseudomonas aeruginosa. Front Microbiol 13:987656","DOI":"10.3389\/fmicb.2022.987656"},{"issue":"4","key":"5118_CR165","doi-asserted-by":"publisher","first-page":"e00092","DOI":"10.1128\/msystems.00092-22","volume":"7","author":"SD Ahator","year":"2022","unstructured":"Ahator SD et al (2022) Nutrient availability and phage exposure alter the quorum-sensing and CRISPR-Cas-controlled population dynamics of pseudomonas aeruginosa. mSystems 7(4):e00092\u2013e00022","journal-title":"mSystems"},{"issue":"1","key":"5118_CR177","doi-asserted-by":"publisher","first-page":"80","DOI":"10.20411\/pai.v10i1.777","volume":"10","author":"D Al Ismail","year":"2024","unstructured":"Al Ismail D et al (2024) Hypervirulent klebsiella pneumoniae (hvKp): overview, epidemiology, and laboratory detection. Pathog Immun 10(1):80\u2013119","journal-title":"Pathog Immun"},{"issue":"17","key":"5118_CR244","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.3390\/diagnostics15172244","volume":"15","author":"AD Alatawi","year":"2025","unstructured":"Alatawi AD et al (2025) Diagnostic innovations to combat antibiotic resistance in critical care: tools for targeted therapy and stewardship. Diagnostics 15(17):2244","journal-title":"Diagnostics"},{"issue":"2","key":"5118_CR64","doi-asserted-by":"publisher","first-page":"229","DOI":"10.35787\/jimdc.v15i2.1616","volume":"15","author":"U Ali","year":"2026","unstructured":"Ali U et al (2026) Beyond infection: the global health and economic burden of antimicrobial resistance. J Islamabad Med Dent Coll 15(2):229\u2013236","journal-title":"J Islamabad Med Dent Coll"},{"key":"5118_CR72","doi-asserted-by":"publisher","first-page":"100254","DOI":"10.1016\/j.microb.2025.100254","volume":"6","author":"CV Alisigwe","year":"2025","unstructured":"Alisigwe CV, Ikpa CS, Otuonye UJ (2025) Examining alternative approaches to antibiotic utilisation: a critical evaluation of phage therapy and antimicrobial peptides combination as potential alternatives. Microbe 6:100254","journal-title":"Microbe"},{"issue":"1","key":"5118_CR204","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s44446-026-00064-4","volume":"34","author":"FM Almufarriji","year":"2026","unstructured":"Almufarriji FM (2026) Nanocarrier-mediated CRISPR-Cas delivery: a novel approach against antibiotic-resistant superbugs. Saudi Pharm J 34(1):5","journal-title":"Saudi Pharm J"},{"issue":"9","key":"5118_CR176","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00203-026-04988-2","volume":"208","author":"AA Alvi","year":"2026","unstructured":"Alvi AA et al (2026) CRISPR-based gene editing for antimicrobial resistance control in human medicine. Arch Microbiol 208(9):433","journal-title":"Arch Microbiol"},{"key":"5118_CR243","doi-asserted-by":"publisher","first-page":"1865548","DOI":"10.3389\/fmicb.2026.1865548","volume":"17","author":"AJ Alzahrani","year":"2026","unstructured":"Alzahrani AJ (2026) Bacteriophage therapy against multidrug resistant bacterial infections demonstrates clinical advances and engineering innovations between 2020\u20132026. Front Microbiol 17:1865548","journal-title":"Front Microbiol"},{"key":"5118_CR102","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1745-6150-5-43","volume":"5","author":"V Anantharaman","year":"2010","unstructured":"Anantharaman V, Iyer LM, Aravind L (2010) Presence of a classical RRM-fold palm domain in Thg1-type 3\u2019- 5\u2019nucleic acid polymerases and the origin of the GGDEF and CRISPR polymerase domains. Biol Direct 5:43","journal-title":"Biol Direct"},{"issue":"3","key":"5118_CR151","doi-asserted-by":"publisher","first-page":"e70349","DOI":"10.1002\/mbo3.70349","volume":"15","author":"S Arooj","year":"2026","unstructured":"Arooj S et al (2026) Lung microbiome diversity, infection dynamics, and microbe-mediated cross-protection. MicrobiologyOpen 15(3):e70349","journal-title":"MicrobiologyOpen"},{"issue":"1","key":"5118_CR209","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s11033-026-12143-9","volume":"53","author":"S Asgharzadeh","year":"2026","unstructured":"Asgharzadeh S, Pourhajibagher M, Bahador A (2026) Bacterial extracellular vesicles: emerging players in antimicrobial resistance and clinical translation. Mol Biol Rep 53(1):953","journal-title":"Mol Biol Rep"},{"issue":"1","key":"5118_CR56","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41479-022-00096-z","volume":"14","author":"M Assefa","year":"2022","unstructured":"Assefa M (2022) Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns. Pneumonia (Nathan) 14(1):4","journal-title":"Pneumonia (Nathan)"},{"key":"5118_CR207","doi-asserted-by":"crossref","unstructured":"Ates A et al (2026) Lipoplex as a useful tool for resensitization of methicillin-resistant Staphylococcus aureus to erythromycin via CRISPR-Cas technology. Int J Pharm 127105","DOI":"10.1016\/j.ijpharm.2026.127105"},{"issue":"3","key":"5118_CR242","first-page":"e43","volume":"37","author":"RN Aziz","year":"2025","unstructured":"Aziz RN et al (2025) Bacterial dormancy: strategies and molecular mechanisms for a sleeping beauty system. Reviews Res Med Microbiol 37(3):e43\u2013e55","journal-title":"Reviews Res Med Microbiol"},{"issue":"null","key":"5118_CR179","first-page":"548733","volume":"19","author":"S Bani Abdel-Rahman","year":"2026","unstructured":"Bani Abdel-Rahman S et al (2026) Hypervirulent and drug-resistant klebsiella pneumoniae: clinical challenges and alternative treatment strategies. Int J Gen Med 19(null):548733","journal-title":"Int J Gen Med"},{"issue":"5819","key":"5118_CR85","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1126\/science.1138140","volume":"315","author":"R Barrangou","year":"2007","unstructured":"Barrangou R et al (2007) CRISPR provides acquired resistance against viruses in prokaryotes. Science 315(5819):1709\u20131712","journal-title":"Science"},{"issue":"6268","key":"5118_CR6","doi-asserted-by":"publisher","first-page":"aad3292","DOI":"10.1126\/science.aad3292","volume":"351","author":"M Baym","year":"2016","unstructured":"Baym M, Stone LK, Kishony R (2016) Multidrug evolutionary strategies to reverse antibiotic resistance. Science 351(6268):aad3292","journal-title":"Science"},{"issue":"11","key":"5118_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00203-025-04464-3","volume":"207","author":"B Behera","year":"2025","unstructured":"Behera B et al (2025) A comprehensive review of advanced strategies to combat antimicrobial resistance. Arch Microbiol 207(11):281","journal-title":"Arch Microbiol"},{"key":"5118_CR25","doi-asserted-by":"publisher","first-page":"1444781","DOI":"10.3389\/fphar.2024.1444781","volume":"15","author":"WY Belay","year":"2024","unstructured":"Belay WY et al (2024) Mechanism of antibacterial resistance, strategies and next-generation antimicrobials to contain antimicrobial resistance: a review. Front Pharmacol 15:1444781","journal-title":"Front Pharmacol"},{"key":"5118_CR91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-genet-110410-132430","volume":"45","author":"D Bhaya","year":"2011","unstructured":"Bhaya D, Davison M, Barrangou R (2011) CRISPR-Cas systems in bacteria and archaea: versatile small RNAs for adaptive defense and regulation. Annu Rev Genet 45:273\u2013297","journal-title":"Annu Rev Genet"},{"issue":"11","key":"5118_CR114","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","volume":"32","author":"D Bikard","year":"2014","unstructured":"Bikard D et al (2014) Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 32(11):1146\u20131150","journal-title":"Nat Biotechnol"},{"issue":"11","key":"5118_CR171","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1038\/nbt.3043","volume":"32","author":"D Bikard","year":"2014","unstructured":"Bikard D et al (2014) Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials. Nat Biotechnol 32(11):1146\u20131150","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5118_CR35","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/nrmicro3380","volume":"13","author":"JM Blair","year":"2015","unstructured":"Blair JM et al (2015) Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13(1):42\u201351","journal-title":"Nat Rev Microbiol"},{"key":"5118_CR123","doi-asserted-by":"crossref","unstructured":"Bloem A et al (2021) New-generation antibiotics for treatment of gram-positive infections: a review with focus on endocarditis and osteomyelitis. J Clin Med 10(8):1743","DOI":"10.3390\/jcm10081743"},{"key":"5118_CR59","doi-asserted-by":"publisher","first-page":"601","DOI":"10.21786\/bbrc\/12.3\/8","volume":"12","author":"K Bonhi","year":"2019","unstructured":"Bonhi K, Imran S (2019) Role of bacteriocin in tackling the global problem of multi-drug resistance: an updated review. Biosci Biotechnol Res Commun 12:601\u2013608","journal-title":"Biosci Biotechnol Res Commun"},{"key":"5118_CR27","doi-asserted-by":"crossref","unstructured":"Breijyeh Z, Jubeh B, Karaman R (2020) Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules 25(6):1340","DOI":"10.3390\/molecules25061340"},{"issue":"4","key":"5118_CR4","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00248-017-0985-z","volume":"74","author":"L Brinkac","year":"2017","unstructured":"Brinkac L et al (2017) The Threat of Antimicrobial Resistance on the Human Microbiome. Microb Ecol 74(4):1001\u20131008","journal-title":"Microb Ecol"},{"issue":"8","key":"5118_CR167","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1038\/s41396-021-00946-6","volume":"15","author":"JM Broniewski","year":"2021","unstructured":"Broniewski JM et al (2021) The effect of Quorum sensing inhibitors on the evolution of CRISPR-based phage immunity in Pseudomonas aeruginosa. ISME J 15(8):2465\u20132473","journal-title":"ISME J"},{"issue":"5891","key":"5118_CR87","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1126\/science.1159689","volume":"321","author":"SJ Brouns","year":"2008","unstructured":"Brouns SJ et al (2008) Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 321(5891):960\u2013964","journal-title":"Science"},{"issue":"8","key":"5118_CR48","doi-asserted-by":"publisher","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","volume":"6","author":"K Bush","year":"2016","unstructured":"Bush K, Bradford PA (2016) \u03b2-Lactams and \u03b2-lactamase inhibitors: an overview. Cold Spring Harbor Perspect Med 6(8):a025247","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"5118_CR193","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s42003-018-0041-7","volume":"1","author":"J Cairns","year":"2018","unstructured":"Cairns J et al (2018) Ecology determines how low antibiotic concentration impacts community composition and horizontal transfer of resistance genes. Commun biology 1(1):35","journal-title":"Commun biology"},{"issue":"6","key":"5118_CR32","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","volume":"104","author":"EA Campbell","year":"2001","unstructured":"Campbell EA et al (2001) Structural mechanism for rifampicin inhibition of bacterial rna polymerase. Cell 104(6):901\u2013912","journal-title":"Cell"},{"issue":"1","key":"5118_CR174","first-page":"26191","volume":"26","author":"S Carding","year":"2015","unstructured":"Carding S et al (2015) Dysbiosis of the gut microbiota in disease. Microb Ecol health disease 26(1):26191","journal-title":"Microb Ecol health disease"},{"issue":"1","key":"5118_CR221","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1038\/s41467-020-20065-8","volume":"11","author":"J Carlson-Stevermer","year":"2020","unstructured":"Carlson-Stevermer J et al (2020) Design of efficacious somatic cell genome editing strategies for recessive and polygenic diseases. Nat Commun 11(1):6277","journal-title":"Nat Commun"},{"issue":"24","key":"5118_CR88","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1101\/gad.1742908","volume":"22","author":"J Carte","year":"2008","unstructured":"Carte J et al (2008) Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Genes Dev 22(24):3489\u20133496","journal-title":"Genes Dev"},{"issue":"2","key":"5118_CR239","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth CT et al (2019) Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat Med 25(2):249\u2013254","journal-title":"Nat Med"},{"key":"5118_CR57","doi-asserted-by":"publisher","first-page":"119301","DOI":"10.1016\/j.lfs.2021.119301","volume":"274","author":"A Chauhan","year":"2021","unstructured":"Chauhan A et al (2021) Comprehensive review on mechanism of action, resistance and evolution of antimycobacterial drugs. Life Sci 274:119301","journal-title":"Life Sci"},{"issue":"7676","key":"5118_CR216","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature24268","volume":"550","author":"JS Chen","year":"2017","unstructured":"Chen JS et al (2017) Enhanced proofreading governs CRISPR-Cas9 targeting accuracy. Nature 550(7676):407\u2013410","journal-title":"Nature"},{"issue":"19","key":"5118_CR248","doi-asserted-by":"publisher","first-page":"14315","DOI":"10.1021\/acs.analchem.6c00663","volume":"98","author":"Z Chen","year":"2026","unstructured":"Chen Z et al (2026) String-powered microfluidic chip integrating heparin-mediated one-pot RT-RPA\/CRISPR-Cas12a for multiplex detection of HFMD viruses. Anal Chem 98(19):14315\u201314329","journal-title":"Anal Chem"},{"issue":"11","key":"5118_CR117","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik RJ, Mimee M, Lu TK (2014) Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 32(11):1141\u20131145","journal-title":"Nat Biotechnol"},{"issue":"11","key":"5118_CR172","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/nbt.3011","volume":"32","author":"RJ Citorik","year":"2014","unstructured":"Citorik RJ, Mimee M, Lu TK (2014) Sequence-specific antimicrobials using efficiently delivered RNA-guided nucleases. Nat Biotechnol 32(11):1141\u20131145","journal-title":"Nat Biotechnol"},{"issue":"6121","key":"5118_CR101","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L et al (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339(6121):819\u2013823","journal-title":"Science"},{"issue":"23","key":"5118_CR21","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1021\/acs.biochem.5b00109","volume":"54","author":"MJ Culyba","year":"2015","unstructured":"Culyba MJ, Mo CY, Kohli RM (2015) Targets for combating the evolution of acquired antibiotic resistance. Biochemistry 54(23):3573\u20133582","journal-title":"Biochemistry"},{"key":"5118_CR54","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3389\/fmicb.2019.01941","volume":"10","author":"I Dandachi","year":"2019","unstructured":"Dandachi I et al (2019) Understanding the epidemiology of multi-drug resistant gram-negative bacilli in the middle east using a one health approach. Front Microbiol 10:1941","journal-title":"Front Microbiol"},{"issue":"5","key":"5118_CR220","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nchembio.1793","volume":"11","author":"KM Davis","year":"2015","unstructured":"Davis KM et al (2015) Small molecule-triggered Cas9 protein with improved genome-editing specificity. Nat Chem Biol 11(5):316\u2013318","journal-title":"Nat Chem Biol"},{"issue":"2","key":"5118_CR67","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jac\/dkq412","volume":"66","author":"ME de Kraker","year":"2011","unstructured":"de Kraker ME et al (2011) Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 66(2):398\u2013407","journal-title":"J Antimicrob Chemother"},{"issue":"10","key":"5118_CR115","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11274-025-04608-z","volume":"41","author":"HCA de Souza","year":"2025","unstructured":"de Souza HCA et al (2025) CRISPR-Cas systems in combating antimicrobial resistance: which system to choose? A systematic review. World J Microbiol Biotechnol 41(10):381","journal-title":"World J Microbiol Biotechnol"},{"issue":"7340","key":"5118_CR100","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/nature09886","volume":"471","author":"E Deltcheva","year":"2011","unstructured":"Deltcheva E et al (2011) CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 471(7340):602\u2013607","journal-title":"Nature"},{"issue":"5","key":"5118_CR105","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1111\/mmi.12152","volume":"87","author":"L Deng","year":"2013","unstructured":"Deng L et al (2013) A novel interference mechanism by a type IIIB CRISPR-Cmr module in sulfolobus. Mol Microbiol 87(5):1088\u20131099","journal-title":"Mol Microbiol"},{"issue":"1","key":"5118_CR182","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijantimicag.2018.09.017","volume":"53","author":"H Dong","year":"2019","unstructured":"Dong H et al (2019) Exploiting a conjugative CRISPR\/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. Int J Antimicrob Agents 53(1):1\u20138","journal-title":"Int J Antimicrob Agents"},{"issue":"6213","key":"5118_CR195","doi-asserted-by":"publisher","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) The new frontier of genome engineering with CRISPR-Cas9. Science 346(6213):1258096","journal-title":"Science"},{"issue":"2","key":"5118_CR192","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/1047-8477(91)90018-R","volume":"107","author":"M D\u00fcrrenberger","year":"1991","unstructured":"D\u00fcrrenberger M, Villiger W, B\u00e4chi T (1991) Conjugational junctions: morphology of specific contacts in conjugating Escherichia coli bacteria. J Struct Biol 107(2):146\u2013156","journal-title":"J Struct Biol"},{"issue":"1","key":"5118_CR233","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1186\/s12967-026-08175-1","volume":"24","author":"W Du","year":"2026","unstructured":"Du W et al (2026) Deep learning\u2013driven prediction of on-target activity, off-target risk, and repair outcomes in CRISPR\/Cas9: current landscape and multi-scale perspectives. J Translational Med 24(1):769","journal-title":"J Translational Med"},{"key":"5118_CR158","doi-asserted-by":"crossref","unstructured":"Dziuba A et al (2023) Comparative study of virulence potential, phylogenetic origin, CRISPR-Cas regions and drug resistance of Escherichia coli isolates from urine and other clinical materials. Front Microbiol 14\u20132023","DOI":"10.3389\/fmicb.2023.1289683"},{"issue":"3","key":"5118_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/ph18030402","volume":"18","author":"ME Elshobary","year":"2025","unstructured":"Elshobary ME et al (2025) Combating antibiotic resistance: mechanisms, multidrug-resistant pathogens, and novel therapeutic approaches: an updated review. Pharmaceuticals 18(3):402","journal-title":"Pharmaceuticals"},{"issue":"1","key":"5118_CR149","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-019-0561-6","volume":"26","author":"HA Farrag","year":"2019","unstructured":"Farrag HA et al (2019) Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria. J Biomed Sci 26(1):69","journal-title":"J Biomed Sci"},{"issue":"1","key":"5118_CR181","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12866-026-04940-w","volume":"26","author":"D Fern\u00e1ndez-Salvatierra","year":"2026","unstructured":"Fern\u00e1ndez-Salvatierra D et al (2026) Co-occurrence of blaKPC and blaOXA\u2009\u2013\u200948 genes in Klebsiella pneumoniae isolates from a tertiary-care hospital in Ecuador and evidence of emerging genotypic\u2013phenotypic AMR inconsistencies. BMC Microbiol 26(1):401","journal-title":"BMC Microbiol"},{"key":"5118_CR29","doi-asserted-by":"crossref","unstructured":"Galgano M et al (2025) Acquired bacterial resistance to antibiotics and resistance genes: from past to future. Antibiot (Basel) 14(3):222","DOI":"10.3390\/antibiotics14030222"},{"issue":"8","key":"5118_CR228","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/nbt.3900","volume":"35","author":"L Gao","year":"2017","unstructured":"Gao L et al (2017) Engineered Cpf1 variants with altered PAM specificities. Nat Biotechnol 35(8):789\u2013792","journal-title":"Nat Biotechnol"},{"issue":"7320","key":"5118_CR86","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature09523","volume":"468","author":"JE Garneau","year":"2010","unstructured":"Garneau JE et al (2010) The CRISPR\/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 468(7320):67\u201371","journal-title":"Nature"},{"issue":"7714","key":"5118_CR235","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1038\/s41586-018-0070-x","volume":"559","author":"NM Gaudelli","year":"2018","unstructured":"Gaudelli NM et al (2018) Publisher Correction: Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 559(7714):E8","journal-title":"Nature"},{"issue":"1","key":"5118_CR200","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s13659-025-00567-y","volume":"16","author":"C Ghazaei","year":"2026","unstructured":"Ghazaei C (2026) The role of bacteriophages and CRISPR-Cas in combating multidrug-resistant bacteria. Nat Prod Bioprospecting 16(1):14","journal-title":"Nat Prod Bioprospecting"},{"key":"5118_CR154","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2147\/IDR.S247271","volume":"13","author":"P Gholizadeh","year":"2020","unstructured":"Gholizadeh P et al (2020) How CRISPR-Cas system could be used to combat antimicrobial resistance. Infect Drug Resist 13:1111\u20131121","journal-title":"Infect Drug Resist"},{"issue":"3","key":"5118_CR237","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.cell.2014.09.029","volume":"159","author":"LA Gilbert","year":"2014","unstructured":"Gilbert LA et al (2014) Genome-scale CRISPR-mediated control of gene repression and activation. Cell 159(3):647\u2013661","journal-title":"Cell"},{"issue":"1","key":"5118_CR147","doi-asserted-by":"publisher","first-page":"e00928","DOI":"10.1128\/mBio.00928-13","volume":"5","author":"AA Gomaa","year":"2014","unstructured":"Gomaa AA et al (2014) Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. mBio 5(1):e00928\u2013e00913","journal-title":"mBio"},{"key":"5118_CR170","doi-asserted-by":"publisher","unstructured":"Gomaa AA et al (2014) Programmable removal of bacterial strains by use of genome-targeting CRISPR-Cas systems. MBio 5(1). https:\/\/doi.org\/10.1128\/mbio.00928-13","DOI":"10.1128\/mbio.00928-13"},{"issue":"4","key":"5118_CR40","doi-asserted-by":"publisher","first-page":"a025387","DOI":"10.1101\/cshperspect.a025387","volume":"6","author":"TH Grossman","year":"2016","unstructured":"Grossman TH (2016) Tetracycline antibiotics and resistance. Cold Spring Harbor Perspect Med 6(4):a025387","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"1","key":"5118_CR126","doi-asserted-by":"publisher","first-page":"17801","DOI":"10.1038\/s41598-021-97224-4","volume":"11","author":"S Gupta","year":"2021","unstructured":"Gupta S et al (2021) Targeting of Uropathogenic Escherichia coli papG gene using CRISPR-dot nanocomplex reduced virulence of UPEC. Sci Rep 11(1):17801","journal-title":"Sci Rep"},{"issue":"5","key":"5118_CR68","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S1470-2045(25)00128-7","volume":"26","author":"V Gupta","year":"2025","unstructured":"Gupta V et al (2025) Incidence and prevalence of antimicrobial resistance in outpatients with cancer: a multicentre, retrospective, cohort study. Lancet Oncol 26(5):620\u2013628","journal-title":"Lancet Oncol"},{"issue":"3","key":"5118_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/femsre\/fux010","volume":"41","author":"CW Hall","year":"2017","unstructured":"Hall CW, Mah T-F (2017) Molecular mechanisms of biofilm-based antibiotic resistance and tolerance in pathogenic bacteria. FEMS Microbiol Rev 41(3):276\u2013301","journal-title":"FEMS Microbiol Rev"},{"key":"5118_CR184","doi-asserted-by":"publisher","unstructured":"Hao M et al (2020) CRISPR-Cas9-mediated carbapenemase gene and plasmid curing in carbapenem-resistant\u2009Enterobacteriaceae. Antimicrob Agents Chemother 64(9). https:\/\/doi.org\/10.1128\/aac.00843-20","DOI":"10.1128\/aac.00843-20"},{"issue":"6416","key":"5118_CR109","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1126\/science.aav4294","volume":"362","author":"LB Harrington","year":"2018","unstructured":"Harrington LB et al (2018) Programmed DNA destruction by miniature CRISPR-Cas14 enzymes. Science 362(6416):839\u2013842","journal-title":"Science"},{"issue":"10","key":"5118_CR137","doi-asserted-by":"publisher","first-page":"e0105421","DOI":"10.1128\/AAC.01054-21","volume":"65","author":"YZ He","year":"2021","unstructured":"He YZ et al (2021) A transposon-associated CRISPR\/Cas9 system specifically eliminates both chromosomal and plasmid-Borne mcr-1 in Escherichia coli. Antimicrob Agents Chemother 65(10):e0105421","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5118_CR136","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/jac\/dkab368","volume":"77","author":"YZ He","year":"2021","unstructured":"He YZ et al (2021) Re-engineering a mobile-CRISPR\/Cas9 system for antimicrobial resistance gene curing and immunization in Escherichia coli. J Antimicrob Chemother 77(1):74\u201382","journal-title":"J Antimicrob Chemother"},{"key":"5118_CR178","doi-asserted-by":"crossref","unstructured":"Hetta HF et al (2025) Hypervirulent Klebsiella pneumoniae: insights into virulence, antibiotic resistance, and fight strategies against a superbug. Pharmaceuticals (Basel) 18(5)","DOI":"10.3390\/ph18050724"},{"key":"5118_CR168","doi-asserted-by":"crossref","unstructured":"H\u00f8yland-Kroghsbo NM et al (2017) Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system. Proc Natl Acad ScI 114(1):131\u2013135","DOI":"10.1073\/pnas.1617415113"},{"issue":"1","key":"5118_CR164","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1073\/pnas.1617415113","volume":"114","author":"NM H\u00f8yland-Kroghsbo","year":"2017","unstructured":"H\u00f8yland-Kroghsbo NM et al (2017) Quorum sensing controls the <\u2009i>Pseudomonas aeruginosa CRISPR-Cas adaptive immune system. Proc Natl Acad Sci 114(1):131\u2013135","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"5118_CR24","doi-asserted-by":"publisher","first-page":"100947","DOI":"10.1016\/j.lanmic.2024.07.010","volume":"6","author":"CS Ho","year":"2025","unstructured":"Ho CS et al (2025) Antimicrobial resistance: a concise update. Lancet Microbe 6(1):100947","journal-title":"Lancet Microbe"},{"issue":"5","key":"5118_CR23","first-page":"464","volume":"23","author":"SB Hoffman","year":"2001","unstructured":"Hoffman SB (2001) Mechanisms of antibiotic resistance. Compendium 23(5):464\u2013473","journal-title":"Compendium"},{"issue":"6","key":"5118_CR80","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","volume":"157","author":"PD Hsu","year":"2014","unstructured":"Hsu PD, Lander ES, Zhang F (2014) Development and applications of CRISPR-Cas9 for genome engineering. Cell 157(6):1262\u20131278","journal-title":"Cell"},{"key":"5118_CR231","doi-asserted-by":"publisher","first-page":"612823","DOI":"10.1155\/2014\/612823","volume":"2014","author":"Z Hu","year":"2014","unstructured":"Hu Z et al (2014) Disruption of HPV16-E7 by CRISPR\/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells. Biomed Res Int 2014:612823","journal-title":"Biomed Res Int"},{"issue":"7699","key":"5118_CR217","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature26155","volume":"556","author":"JH Hu","year":"2018","unstructured":"Hu JH et al (2018) Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature 556(7699):57\u201363","journal-title":"Nature"},{"issue":"7","key":"5118_CR232","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/s41591-018-0050-6","volume":"24","author":"RJ Ihry","year":"2018","unstructured":"Ihry RJ et al (2018) p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med 24(7):939\u2013946","journal-title":"Nat Med"},{"key":"5118_CR36","doi-asserted-by":"crossref","unstructured":"Iredell J, Brown J, Tagg K (2016) Antibiotic resistance in Enterobacteriaceae: mechanisms and clinical implications. BMJ 352","DOI":"10.1136\/bmj.h6420"},{"issue":"12","key":"5118_CR78","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1128\/jb.169.12.5429-5433.1987","volume":"169","author":"Y Ishino","year":"1987","unstructured":"Ishino Y et al (1987) Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol 169(12):5429\u20135433","journal-title":"J Bacteriol"},{"key":"5118_CR202","doi-asserted-by":"publisher","first-page":"1812871","DOI":"10.3389\/fmicb.2026.1812871","volume":"17","author":"MS Islam","year":"2026","unstructured":"Islam MS et al (2026) Phage enabled precision drug delivery: dual function platforms for therapeutics and genetic cargo transport. Front Microbiol 17:1812871","journal-title":"Front Microbiol"},{"issue":"168","key":"5118_CR5","doi-asserted-by":"publisher","first-page":"20200105","DOI":"10.1098\/rsif.2020.0105","volume":"17","author":"E Jacopin","year":"2020","unstructured":"Jacopin E et al (2020) Factors favouring the evolution of multidrug resistance in bacteria. J Royal Soc Interface 17(168):20200105","journal-title":"J Royal Soc Interface"},{"key":"5118_CR153","doi-asserted-by":"crossref","unstructured":"Javed MU et al (2023) CRISPR-Cas9 system: a prospective pathway toward combatting antibiotic resistance. Antibiot (Basel) 12(6)","DOI":"10.3390\/antibiotics12061075"},{"issue":"6096","key":"5118_CR99","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M et al (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337(6096):816\u2013821","journal-title":"Science"},{"issue":"6176","key":"5118_CR110","doi-asserted-by":"publisher","first-page":"1247997","DOI":"10.1126\/science.1247997","volume":"343","author":"M Jinek","year":"2014","unstructured":"Jinek M et al (2014) Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 343(6176):1247997","journal-title":"Science"},{"key":"5118_CR198","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12575-020-00135-3","volume":"22","author":"S Jolany Vangah","year":"2020","unstructured":"Jolany Vangah S et al (2020) CRISPR-based diagnosis of infectious and noninfectious diseases. Biol Proced Online 22:22","journal-title":"Biol Proced Online"},{"issue":"10","key":"5118_CR111","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1111\/j.1462-5822.2012.01816.x","volume":"14","author":"CL Jones","year":"2012","unstructured":"Jones CL et al (2012) Repression of bacterial lipoprotein production by F rancisella novicida facilitates evasion of innate immune recognition. Cell Microbiol 14(10):1531\u20131543","journal-title":"Cell Microbiol"},{"issue":"5","key":"5118_CR94","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nsmb.2019","volume":"18","author":"MM Jore","year":"2011","unstructured":"Jore MM et al (2011) Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat Struct Mol Biol 18(5):529\u2013536","journal-title":"Nat Struct Mol Biol"},{"key":"5118_CR173","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.3389\/fmicb.2019.02934","volume":"10","author":"M Kamruzzaman","year":"2020","unstructured":"Kamruzzaman M, Iredell JR (2020) CRISPR-Cas system in antibiotic resistance plasmids in Klebsiella pneumoniae. Front Microbiol 10:2934","journal-title":"Front Microbiol"},{"issue":"4","key":"5118_CR141","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1021\/acs.bioconjchem.6b00676","volume":"28","author":"YK Kang","year":"2017","unstructured":"Kang YK et al (2017) Nonviral genome editing based on a polymer-derivatized CRISPR nanocomplex for targeting bacterial pathogens and antibiotic resistance. Bioconjug Chem 28(4):957\u2013967","journal-title":"Bioconjug Chem"},{"issue":"3","key":"5118_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.4103\/joacp.JOACP_349_15","volume":"33","author":"G Kapoor","year":"2017","unstructured":"Kapoor G, Saigal S, Elongavan A (2017) Action and resistance mechanisms of antibiotics: A guide for clinicians. J Anaesthesiol Clin Pharmacol 33(3):300\u2013305","journal-title":"J Anaesthesiol Clin Pharmacol"},{"key":"5118_CR144","doi-asserted-by":"publisher","first-page":"100173","DOI":"10.1016\/j.medmic.2026.100173","volume":"28","author":"KK Karunakar","year":"2026","unstructured":"Karunakar KK et al (2026) Microecological control of antimicrobial resistance using CRISPR-based precision interventions. Med Microecology 28:100173","journal-title":"Med Microecology"},{"key":"5118_CR199","doi-asserted-by":"publisher","first-page":"149180","DOI":"10.1016\/j.ijbiomac.2025.149180","volume":"334","author":"MF Khan","year":"2025","unstructured":"Khan MF et al (2025) CRISPR-Cas mediated targeting of resistance genes for combating ESKAPE pathogen infections: a review. Int J Biol Macromol 334:149180","journal-title":"Int J Biol Macromol"},{"key":"5118_CR112","doi-asserted-by":"crossref","unstructured":"Kieper SN, Almendros C, Brouns SJ (2019) Conserved motifs in the CRISPR leader sequence control spacer acquisition levels in Type ID CRISPR-Cas systems. FEMS Microbiol Lett 366(11):fnz129","DOI":"10.1093\/femsle\/fnz129"},{"issue":"1","key":"5118_CR143","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1038\/s41467-020-16731-6","volume":"11","author":"K Kiga","year":"2020","unstructured":"Kiga K et al (2020) Development of CRISPR-Cas13a-based antimicrobials capable of sequence-specific killing of target bacteria. Nat Commun 11(1):2934","journal-title":"Nat Commun"},{"issue":"6","key":"5118_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.3390\/antibiotics15060526","volume":"15","author":"T-J Kim","year":"2026","unstructured":"Kim T-J (2026) Bacterial persister cells as evolutionary catalysts of antibiotic resistance: mechanisms, clinical implications, and therapeutic strategies. Antibiotics 15(6):526","journal-title":"Antibiotics"},{"issue":"2","key":"5118_CR185","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4014\/jmb.1508.08080","volume":"26","author":"J-S Kim","year":"2016","unstructured":"Kim J-S et al (2016) CRISPR\/Cas9-mediated re-sensitization of antibiotic-resistant Escherichia coli harboring extended-spectrum \u03b2-lactamases. J Microbiol Biotechnol 26(2):394\u2013401","journal-title":"J Microbiol Biotechnol"},{"issue":"2","key":"5118_CR116","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4014\/jmb.1508.08080","volume":"26","author":"JS Kim","year":"2016","unstructured":"Kim JS et al (2016) CRISPR\/Cas9-mediated re-sensitization of antibiotic-resistant escherichia coli harboring extended-spectrum \u03b2-lactamases. J Microbiol Biotechnol 26(2):394\u2013401","journal-title":"J Microbiol Biotechnol"},{"issue":"3","key":"5118_CR229","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/nbt.4061","volume":"36","author":"HK Kim","year":"2018","unstructured":"Kim HK et al (2018) Deep learning improves prediction of CRISPR-Cpf1 guide RNA activity. Nat Biotechnol 36(3):239\u2013241","journal-title":"Nat Biotechnol"},{"issue":"7561","key":"5118_CR227","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature14592","volume":"523","author":"BP Kleinstiver","year":"2015","unstructured":"Kleinstiver BP et al (2015) Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature 523(7561):481\u2013485","journal-title":"Nature"},{"issue":"7603","key":"5118_CR234","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC et al (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533(7603):420\u2013424","journal-title":"Nature"},{"key":"5118_CR194","doi-asserted-by":"crossref","unstructured":"Kundar R, Gokarn K (2022) CRISPR-Cas system: a tool to eliminate drug-resistant gram-negative bacteria. Pharmaceuticals (Basel) 15(12)","DOI":"10.3390\/ph15121498"},{"issue":"4","key":"5118_CR134","doi-asserted-by":"publisher","first-page":"e0009322","DOI":"10.1128\/aac.00093-22","volume":"66","author":"N Kurepina","year":"2022","unstructured":"Kurepina N et al (2022) CRISPR inhibition of essential peptidoglycan biosynthesis genes in mycobacterium abscessus and its impact on \u03b2-lactam susceptibility. Antimicrob Agents Chemother 66(4):e0009322","journal-title":"Antimicrob Agents Chemother"},{"key":"5118_CR238","doi-asserted-by":"publisher","first-page":"15315","DOI":"10.1038\/ncomms15315","volume":"8","author":"DY Kwon","year":"2017","unstructured":"Kwon DY et al (2017) Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC. Nat Commun 8:15315","journal-title":"Nat Commun"},{"issue":"10","key":"5118_CR31","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.addr.2005.04.003","volume":"57","author":"PA Lambert","year":"2005","unstructured":"Lambert PA (2005) Bacterial resistance to antibiotics: modified target sites. Adv Drug Deliv Rev 57(10):1471\u20131485","journal-title":"Adv Drug Deliv Rev"},{"key":"5118_CR58","doi-asserted-by":"publisher","first-page":"e1567","DOI":"10.1136\/bmj.e1567","volume":"344","author":"R Laxminarayan","year":"2012","unstructured":"Laxminarayan R, Heymann DL (2012) Challenges of drug resistance in the developing world. BMJ 344:e1567","journal-title":"BMJ"},{"issue":"12","key":"5118_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/S1473-3099(13)70318-9","volume":"13","author":"R Laxminarayan","year":"2013","unstructured":"Laxminarayan R et al (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13(12):1057\u20131098","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"5118_CR215","doi-asserted-by":"publisher","first-page":"3048","DOI":"10.1038\/s41467-018-05477-x","volume":"9","author":"JK Lee","year":"2018","unstructured":"Lee JK et al (2018) Directed evolution of CRISPR-Cas9 to increase its specificity. Nat Commun 9(1):3048","journal-title":"Nat Commun"},{"issue":"1","key":"5118_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1139\/cjm-2018-0275","volume":"65","author":"NA Lerminiaux","year":"2019","unstructured":"Lerminiaux NA, Cameron AD (2019) Horizontal transfer of antibiotic resistance genes in clinical environments. Can J Microbiol 65(1):34\u201344","journal-title":"Can J Microbiol"},{"issue":"8","key":"5118_CR190","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nbt.2661","volume":"31","author":"D Li","year":"2013","unstructured":"Li D et al (2013) Heritable gene targeting in the mouse and rat using a CRISPR-Cas system. Nat Biotechnol 31(8):681\u2013683","journal-title":"Nat Biotechnol"},{"key":"5118_CR222","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.biomaterials.2018.04.031","volume":"171","author":"L Li","year":"2018","unstructured":"Li L, Hu S, Chen X (2018) Non-viral delivery systems for CRISPR\/Cas9-based genome editing: challenges and opportunities. Biomaterials 171:207\u2013218","journal-title":"Biomaterials"},{"key":"5118_CR135","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2147\/IDR.S357470","volume":"15","author":"P Li","year":"2022","unstructured":"Li P et al (2022) Targeted elimination of bla (NDM-5) gene in Escherichia coli by conjugative CRISPR-Cas9 system. Infect Drug Resist 15:1707\u20131716","journal-title":"Infect Drug Resist"},{"key":"5118_CR203","doi-asserted-by":"crossref","unstructured":"Li B et al (2026) Research progress and medical applications of material-functionalized phages. Microbes Immunity 025010143","DOI":"10.36922\/MI025010143"},{"issue":"1","key":"5118_CR121","doi-asserted-by":"publisher","first-page":"e70986","DOI":"10.1111\/jcmm.70986","volume":"30","author":"M-F Li","year":"2026","unstructured":"Li M-F et al (2026) Disrupting viral persistence: CRISPR\/Cas9-based strategies for hepatitis B and C treatment, and challenges. J Cell Mol Med 30(1):e70986","journal-title":"J Cell Mol Med"},{"key":"5118_CR42","doi-asserted-by":"crossref","unstructured":"Lin J et al (2015) Mechanisms of antibiotic resistance. Front Media SA. pp. 34","DOI":"10.3389\/fmicb.2015.00034"},{"issue":"24","key":"5118_CR95","doi-asserted-by":"publisher","first-page":"21643","DOI":"10.1074\/jbc.M111.238485","volume":"286","author":"NG Lintner","year":"2011","unstructured":"Lintner NG et al (2011) Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem 286(24):21643\u201321656","journal-title":"J Biol Chem"},{"issue":"42","key":"5118_CR119","doi-asserted-by":"publisher","first-page":"14473","DOI":"10.1074\/jbc.REV120.007034","volume":"295","author":"TY Liu","year":"2020","unstructured":"Liu TY, Doudna JA (2020) Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation. J Biol Chem 295(42):14473\u201314487","journal-title":"J Biol Chem"},{"issue":"Database issue","key":"5118_CR53","doi-asserted-by":"publisher","first-page":"D443","DOI":"10.1093\/nar\/gkn656","volume":"37","author":"B Liu","year":"2009","unstructured":"Liu B, Pop M (2009) ARDB\u2013antibiotic resistance genes database. Nucleic Acids Res 37(Database issue):D443\u2013D447","journal-title":"Nucleic Acids Res"},{"key":"5118_CR139","doi-asserted-by":"crossref","unstructured":"de Maat V et al (2019) CRISPR-Cas9-mediated genome editing in vancomycin-resistant Enterococcus faecium. FEMS Microbiol Lett 366(22)","DOI":"10.1093\/femsle\/fnz256"},{"issue":"3","key":"5118_CR50","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"5118_CR98","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nrmicro2577","volume":"9","author":"KS Makarova","year":"2011","unstructured":"Makarova KS et al (2011) Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 9(6):467\u2013477","journal-title":"Nat Rev Microbiol"},{"issue":"11","key":"5118_CR196","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/nrmicro3569","volume":"13","author":"KS Makarova","year":"2015","unstructured":"Makarova KS et al (2015) An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol 13(11):722\u2013736","journal-title":"Nat Rev Microbiol"},{"key":"5118_CR83","doi-asserted-by":"crossref","unstructured":"Makarova KS et al (2025) An updated evolutionary classification of CRISPR\u2013Cas systems including rare variants. Nat Microbiol 10:1\u201316","DOI":"10.1038\/s41564-025-02180-8"},{"issue":"1","key":"5118_CR145","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s11671-026-04653-z","volume":"21","author":"S Makhijani","year":"2026","unstructured":"Makhijani S et al (2026) From mechanism to medicine: CRISPR\u2013Cas9 delivery strategies, therapeutic applications and translation challenges. Discover Nano 21(1):210","journal-title":"Discover Nano"},{"key":"5118_CR71","doi-asserted-by":"crossref","unstructured":"Alaoui Mdarhri H et al (2022) Alternatives therapeutic approaches to conventional antibiotics: advantages, limitations and potential application in medicine. Antibiot (Basel) 11(12):1826.","DOI":"10.3390\/antibiotics11121826"},{"key":"5118_CR12","first-page":"3","volume":"398","author":"E Medina","year":"2016","unstructured":"Medina E, Pieper DH (2016) Tackling threats and future problems of multidrug-resistant bacteria. Curr Top Microbiol Immunol 398:3\u201333","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"5118_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1021\/acschembio.7b00855","volume":"13","author":"A Mir","year":"2018","unstructured":"Mir A et al (2018) Type II-C CRISPR-Cas9 biology, mechanism, and application. ACS Chem Biol 13(2):357\u2013365","journal-title":"ACS Chem Biol"},{"key":"5118_CR251","first-page":"p","volume":"108290","author":"MT Moghadam","year":"2026","unstructured":"Moghadam MT et al (2026) Pairing antibiotics with phages: a new strategy to tackle biofilms of drug-resistant acinetobacter baumannii\u2014insights from in vitro and in vivo studies. Microb Pathog 108290","journal-title":"Microb Pathog"},{"key":"5118_CR107","doi-asserted-by":"publisher","first-page":"p100184","DOI":"10.1016\/j.microb.2024.100184","volume":"5","author":"A Moitra","year":"2024","unstructured":"Moitra A, Chakraborty A, Dam B (2024) CRISPR-Cas9 system: a potent tool to fight antibiotic resistance in bacteria. Microbe 5:p100184","journal-title":"Microbe"},{"issue":"1","key":"5118_CR79","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1046\/j.1365-2958.2000.01838.x","volume":"36","author":"FJ Mojica","year":"2000","unstructured":"Mojica FJ et al (2000) Biological significance of a family of regularly spaced repeats in the genomes of archaea, bacteria and mitochondria. Mol Microbiol 36(1):244\u2013246","journal-title":"Mol Microbiol"},{"issue":"2","key":"5118_CR81","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00239-004-0046-3","volume":"60","author":"FJ Mojica","year":"2005","unstructured":"Mojica FJ et al (2005) Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 60(2):174\u2013182","journal-title":"J Mol Evol"},{"issue":"8","key":"5118_CR224","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.tibtech.2019.01.009","volume":"37","author":"SB Moon","year":"2019","unstructured":"Moon SB et al (2019) Improving CRISPR genome editing by engineering guide RNAs. Trends Biotechnol 37(8):870\u2013881","journal-title":"Trends Biotechnol"},{"issue":"5","key":"5118_CR76","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1021\/acscentsci.9b01093","volume":"6","author":"EV Moroz-Omori","year":"2020","unstructured":"Moroz-Omori EV et al (2020) Photoswitchable gRNAs for spatiotemporally controlled CRISPR-Cas-based genomic regulation. ACS Cent Sci 6(5):695\u2013703","journal-title":"ACS Cent Sci"},{"issue":"1","key":"5118_CR197","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1139\/cjm-2020-0212","volume":"67","author":"C Mosterd","year":"2021","unstructured":"Mosterd C, Rousseau GM, Moineau S (2021) A short overview of the CRISPR-Cas adaptation stage. Can J Microbiol 67(1):1\u201312","journal-title":"Can J Microbiol"},{"issue":"1","key":"5118_CR250","doi-asserted-by":"publisher","first-page":"1","DOI":"10.60141\/ajid.126","volume":"4","author":"SJ Mousavi","year":"2026","unstructured":"Mousavi SJ, Nazari H, Mosawi SH (2026) Phage-antibiotic combination therapy for antibiotic-resistant bacteria; synergistic mechanisms and clinical applications: a systematic review. Afghanistan J Infect Dis 4(1):1\u201315","journal-title":"Afghanistan J Infect Dis"},{"key":"5118_CR15","doi-asserted-by":"publisher","first-page":"37938","DOI":"10.1038\/srep37938","volume":"6","author":"V M\u00fcller","year":"2016","unstructured":"M\u00fcller V et al (2016) Direct identification of antibiotic resistance genes on single plasmid molecules using CRISPR\/Cas9 in combination with optical DNA mapping. Sci Rep 6:37938","journal-title":"Sci Rep"},{"issue":"1","key":"5118_CR252","doi-asserted-by":"publisher","first-page":"dkaf413","DOI":"10.1093\/jac\/dkaf413","volume":"81","author":"SE Mudde","year":"2026","unstructured":"Mudde SE et al (2026) Omadacycline as a drug candidate for Mycobacterium avium infections: in vitro insights on single and combination therapies. J Antimicrob Chemother 81(1):dkaf413","journal-title":"J Antimicrob Chemother"},{"key":"5118_CR241","doi-asserted-by":"crossref","unstructured":"Mukhopadhyay U et al (2026) CRISPR-enabled antimicrobial strategies: redefining precision therapy against multidrug resistant pathogens. Genet Mol Res","DOI":"10.4238\/8g7e6k51"},{"key":"5118_CR13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS et al (2019) Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol 10:539","journal-title":"Front Microbiol"},{"key":"5118_CR30","doi-asserted-by":"publisher","unstructured":"Munita JM, Arias CA (2016) Mechanisms of antibiotic resistance. Microbiol Spectr 4(2). https:\/\/doi.org\/10.1128\/microbiolspec.vmbf-0016-2015","DOI":"10.1128\/microbiolspec.vmbf-0016-2015"},{"key":"5118_CR41","doi-asserted-by":"crossref","unstructured":"Munita JM, Arias CA (2016) Mechanisms of antibiotic resistance. Virulence Mech bacterial pathogens. pp. 481\u2013511","DOI":"10.1128\/9781555819286.ch17"},{"key":"5118_CR14","doi-asserted-by":"crossref","unstructured":"Murugaiyan J et al (2022) Progress in alternative strategies to combat antimicrobial resistance: focus on antibiotics. Antibiot (Basel) 11(2):200","DOI":"10.3390\/antibiotics11020200"},{"key":"5118_CR45","doi-asserted-by":"crossref","unstructured":"Nadeem MS et al (2026) Genes and physiological strategies in bacterial antibiotic resistance. Front Microbiol 17:2026","DOI":"10.3389\/fmicb.2026.1811959"},{"key":"5118_CR65","doi-asserted-by":"crossref","unstructured":"Naghavi MG. Collaborators (2026) The burden of bacterial antimicrobial resistance in the WHO Western Pacific Region 1990\u20132021: a cross-country systematic analysis with forecasts to 2050. SSRN 6712818","DOI":"10.2139\/ssrn.6712818"},{"issue":"9","key":"5118_CR97","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.str.2012.06.016","volume":"20","author":"KH Nam","year":"2012","unstructured":"Nam KH et al (2012) Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C\/Dvulg CRISPR-Cas system. Structure 20(9):1574\u20131584","journal-title":"Structure"},{"issue":"7","key":"5118_CR3","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1007\/s12015-022-10377-1","volume":"18","author":"A Nath","year":"2022","unstructured":"Nath A et al (2022) Reactive oxygen species in modulating intestinal stem cell dynamics and function. Stem Cell Rev Rep 18(7):2328\u20132350","journal-title":"Stem Cell Rev Rep"},{"issue":"8","key":"5118_CR9","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1084\/jem.20170637","volume":"214","author":"C Nathan","year":"2017","unstructured":"Nathan C (2017) Kunkel Lecture: Fundamental immunodeficiency and its correction. J Exp Med 214(8):2175\u20132191","journal-title":"J Exp Med"},{"issue":"8","key":"5118_CR92","doi-asserted-by":"publisher","first-page":"3645","DOI":"10.3390\/ijms26083645","volume":"26","author":"C Navarro","year":"2025","unstructured":"Navarro C et al (2025) CRISPR-Cas systems: a functional perspective and innovations. Int J Mol Sci 26(8):3645","journal-title":"Int J Mol Sci"},{"issue":"10","key":"5118_CR127","doi-asserted-by":"publisher","first-page":"e10335","DOI":"10.15252\/msb.202110335","volume":"17","author":"K Neil","year":"2021","unstructured":"Neil K et al (2021) High-efficiency delivery of CRISPR-Cas9 by engineered probiotics enables precise microbiome editing. Mol Syst Biol 17(10):e10335","journal-title":"Mol Syst Biol"},{"issue":"6408","key":"5118_CR225","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1126\/science.aas9129","volume":"361","author":"H Nishimasu","year":"2018","unstructured":"Nishimasu H et al (2018) Engineered CRISPR-Cas9 nuclease with expanded targeting space. Science 361(6408):1259\u20131262","journal-title":"Science"},{"key":"5118_CR146","doi-asserted-by":"crossref","unstructured":"Nuevo JJM et al (2026) CRISPR-driven strategies to disrupt methicillin-resistant Staphylococcus aureus biofilms: a review. Front Cell Infect Microbiol 16\u20132026","DOI":"10.3389\/fcimb.2026.1784529"},{"key":"5118_CR122","doi-asserted-by":"publisher","first-page":"6","DOI":"10.53771\/ijlsra.2025.9.1.0042","volume":"9","author":"IN Onyeyili","year":"2025","unstructured":"Onyeyili IN et al (2025) Phage-based CRISPR delivery systems for targeted eradication of drug-resistant bacterial infections. Int J Life Sci Res 9:6\u201334","journal-title":"Int J Life Sci Res"},{"key":"5118_CR1","doi-asserted-by":"crossref","unstructured":"Pacios O et al (2020) Strategies to combat multidrug-resistant and persistent infectious diseases. Antibiot (Basel) 9(2)","DOI":"10.3390\/antibiotics9020065"},{"key":"5118_CR47","doi-asserted-by":"crossref","unstructured":"Page MG (2012) Beta-lactam antibiotics. In: Antibiotic discovery and development. Springer, pp 79\u2013117","DOI":"10.1007\/978-1-4614-1400-1_3"},{"issue":"1","key":"5118_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.biotechadv.2018.11.013","volume":"37","author":"Z Pang","year":"2019","unstructured":"Pang Z et al (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177\u2013192","journal-title":"Biotechnol Adv"},{"key":"5118_CR130","doi-asserted-by":"publisher","first-page":"44929","DOI":"10.1038\/srep44929","volume":"7","author":"JY Park","year":"2017","unstructured":"Park JY et al (2017) Genetic engineering of a temperate phage-based delivery system for CRISPR\/Cas9 antimicrobials against Staphylococcus aureus. Sci Rep 7:44929","journal-title":"Sci Rep"},{"key":"5118_CR62","doi-asserted-by":"crossref","unstructured":"Peptine LD et al (2026) Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) in nosocomial infections: a systematic review of resistance, pathogenesis, and clinical management. Microorganisms 14(2):428","DOI":"10.3390\/microorganisms14020428"},{"key":"5118_CR169","doi-asserted-by":"crossref","unstructured":"Piracha ZZ, Saeed U (2026) Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections. Front Microbiol 17:1748742","DOI":"10.3389\/fmicb.2026.1748742"},{"key":"5118_CR245","doi-asserted-by":"publisher","first-page":"1748742","DOI":"10.3389\/fmicb.2026.1748742","volume":"17","author":"ZZ Piracha","year":"2026","unstructured":"Piracha ZZ, Saeed U (2026) Next-generation bacteriophage therapeutic systems: CRISPR-based engineering, near-infrared bioimaging, and precision strategies for treating multidrug-resistant and extensively drug-resistant bacterial infections. Front Microbiol 17:1748742","journal-title":"Front Microbiol"},{"key":"5118_CR73","doi-asserted-by":"crossref","unstructured":"Plat S, LaPointe G, Goodridge L (2026) Phages as antimicrobials against multi-drug resistant bacteria. Front Microbiol 17:1747240","DOI":"10.3389\/fmicb.2026.1747240"},{"issue":"Pt 3","key":"5118_CR82","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1099\/mic.0.27437-0","volume":"151","author":"C Pourcel","year":"2005","unstructured":"Pourcel C, Salvignol G, Vergnaud G (2005) CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiol (Reading) 151(Pt 3):653\u2013663","journal-title":"Microbiol (Reading)"},{"key":"5118_CR129","doi-asserted-by":"crossref","unstructured":"Price VJ et al (2019) Enterococcus faecalis CRISPR-Cas is a robust barrier to conjugative antibiotic resistance dissemination in the murine intestine. mSphere 4(4)","DOI":"10.1128\/mSphere.00464-19"},{"issue":"6","key":"5118_CR188","doi-asserted-by":"publisher","first-page":"e1006990","DOI":"10.1371\/journal.ppat.1006990","volume":"14","author":"E Pursey","year":"2018","unstructured":"Pursey E et al (2018) CRISPR-Cas antimicrobials: challenges and future prospects. PLoS Pathog 14(6):e1006990","journal-title":"PLoS Pathog"},{"key":"5118_CR63","doi-asserted-by":"crossref","unstructured":"Qin W et al (2026) Global burden of antimicrobial resistance in lower respiratory infections: a systematic analysis for the Global Burden of Disease Study 2021. Int J Antimicrob Agents 107786","DOI":"10.1016\/j.ijantimicag.2026.107786"},{"issue":"3","key":"5118_CR11","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1007\/s12602-025-10676-2","volume":"18","author":"MU Rahman","year":"2026","unstructured":"Rahman MU et al (2026) Innovative approaches to combat antimicrobial resistance: a review of emerging therapies and technologies. Probiotics Antimicrob Proteins 18(3):3597\u20133614","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"1","key":"5118_CR210","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s12602-025-10561-y","volume":"18","author":"R Rahmati","year":"2026","unstructured":"Rahmati R et al (2026) CRISPR-assisted probiotic and in situ engineering of gut microbiota: a prospect to modification of metabolic disorders. Probiotics Antimicrob Proteins 18(1):1570\u20131586","journal-title":"Probiotics Antimicrob Proteins"},{"issue":"10","key":"5118_CR131","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nbt.4203","volume":"36","author":"G Ram","year":"2018","unstructured":"Ram G et al (2018) Conversion of staphylococcal pathogenicity islands to CRISPR-carrying antibacterial agents that cure infections in mice. Nat Biotechnol 36(10):971\u2013976","journal-title":"Nat Biotechnol"},{"issue":"12","key":"5118_CR236","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/s41576-018-0068-0","volume":"19","author":"HA Rees","year":"2018","unstructured":"Rees HA, Liu DR (2018) Publisher Correction: Base editing: precision chemistry on the genome and transcriptome of living cells. Nat Rev Genet 19(12):801","journal-title":"Nat Rev Genet"},{"issue":"3","key":"5118_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3934\/microbiol.2018.3.482","volume":"4","author":"WC Reygaert","year":"2018","unstructured":"Reygaert WC (2018) An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol 4(3):482","journal-title":"AIMS Microbiol"},{"issue":"1","key":"5118_CR175","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1042\/ETLS20170002","volume":"1","author":"DR Roach","year":"2017","unstructured":"Roach DR, Debarbieux L (2017) Phage therapy: awakening a sleeping giant. Emerg Top Life Sci 1(1):93\u2013103","journal-title":"Emerg Top Life Sci"},{"issue":"1","key":"5118_CR230","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13073-015-0215-6","volume":"7","author":"F Robert","year":"2015","unstructured":"Robert F et al (2015) Pharmacological inhibition of DNA-PK stimulates Cas9-mediated genome editing. Genome Med 7(1):93","journal-title":"Genome Med"},{"key":"5118_CR128","doi-asserted-by":"crossref","unstructured":"Rodrigues M et al (2019) Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci. Antimicrob Agents Chemother 63(11)","DOI":"10.1128\/AAC.01454-19"},{"key":"5118_CR8","doi-asserted-by":"crossref","unstructured":"Roope LSJ et al (2019) The challenge of antimicrobial resistance: what economics can contribute. Science 364(6435)","DOI":"10.1126\/science.aau4679"},{"issue":"1","key":"5118_CR253","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.pharmr.2025.100104","volume":"78","author":"CA Roque-Borda","year":"2026","unstructured":"Roque-Borda CA et al (2026) Synergistic combinations of antimicrobial peptides and conventional antibiotics: a strategy to delay resistance emergence in World Health Organization priority bacteria. Pharmacol Rev 78(1):34","journal-title":"Pharmacol Rev"},{"issue":"1","key":"5118_CR43","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s11033-025-11402-5","volume":"53","author":"S Saha","year":"2026","unstructured":"Saha S et al (2026) Breaking resistance: strategies for novel antibacterial therapeutic interventions. Mol Biol Rep 53(1):318","journal-title":"Mol Biol Rep"},{"issue":"6","key":"5118_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00203-026-04817-6","volume":"208","author":"P Sahu","year":"2026","unstructured":"Sahu P, Satapathy T (2026) Beyond new pills: integrative strategies to overcome multidrug-resistant bacteria. Arch Microbiol 208(6):276","journal-title":"Arch Microbiol"},{"key":"5118_CR39","doi-asserted-by":"crossref","unstructured":"Saiffi A et al (2026) Next-generation drug targets for fighting multidrug-resistant bacteria: a review. Curr Pharm Des","DOI":"10.2174\/0113816128406584251028160407"},{"key":"5118_CR44","doi-asserted-by":"crossref","unstructured":"Saini J et al (2025) Revisiting the metallo-\u03b2-lactamase-mediated antibiotic resistance: exploring novel mechanisms and therapeutic strategies. Int J Microbiol 2025:1574819","DOI":"10.1155\/ijm\/1574819"},{"issue":"1","key":"5118_CR163","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13568-021-01269-7","volume":"11","author":"MM Sakr","year":"2021","unstructured":"Sakr MM et al (2021) In vivo evaluation of a recombinant N-acylhomoserine lactonase formulated in a hydrogel using a murine model infected with MDR Pseudomonas aeruginosa clinical isolate, CCASUP2. AMB Express 11(1):109","journal-title":"AMB Express"},{"key":"5118_CR17","doi-asserted-by":"crossref","unstructured":"Schrader SM, Vaubourgeix J, Nathan C (2020) Biology of antimicrobial resistance and approaches to combat it. Sci Transl Med 12(549):eaaz6992","DOI":"10.1126\/scitranslmed.aaz6992"},{"key":"5118_CR52","doi-asserted-by":"crossref","unstructured":"Scoffone VC et al (2024) New antimicrobial strategies to treat multi-drug resistant infections caused by gram-negatives in cystic fibrosis. Antibiot (Basel) 13(1):17","DOI":"10.3390\/antibiotics13010071"},{"key":"5118_CR84","doi-asserted-by":"crossref","unstructured":"Selim HMRM et al (2025) Role of CRISPR-Cas system as a new approach in fighting the antimicrobial resistance of bacterial and viral pathogens. Infect Diseases Immun 5:127\u2013137","DOI":"10.1097\/ID9.0000000000000149"},{"key":"5118_CR132","doi-asserted-by":"crossref","unstructured":"Selle K et al (2020) In vivo targeting of clostridioides difficile using phage-delivered CRISPR-Cas3 antimicrobials. mBio 11(2)","DOI":"10.1128\/mBio.00019-20"},{"key":"5118_CR90","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3389\/fmicb.2016.01292","volume":"7","author":"MA Shabbir","year":"2016","unstructured":"Shabbir MA et al (2016) Bacteria vs. bacteriophages: parallel evolution of immune arsenals. Front Microbiol 7:1292","journal-title":"Front Microbiol"},{"key":"5118_CR89","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3389\/fimmu.2016.00375","volume":"7","author":"MA Shabbir","year":"2016","unstructured":"Shabbir MA et al (2016) Survival and evolution of CRISPR-Cas system in prokaryotes and its applications. Front Immunol 7:375","journal-title":"Front Immunol"},{"key":"5118_CR10","doi-asserted-by":"publisher","first-page":"107399","DOI":"10.1016\/j.micpath.2025.107399","volume":"202","author":"AA Shah","year":"2025","unstructured":"Shah AA et al (2025) Emerging challenges in Klebsiella pneumoniae: antimicrobial resistance and novel approach. Microb Pathog 202:107399","journal-title":"Microb Pathog"},{"issue":"1","key":"5118_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/jamb\/2019\/v19i130185","volume":"19","author":"A Shahriar","year":"2019","unstructured":"Shahriar A et al (2019) Isolation of pathogenic and non-pathogenic microbial stains from different types of sea fish samples and their quality assessment with antibiogram properties. J Adv Microbiol 19(1):1\u201310","journal-title":"J Adv Microbiol"},{"key":"5118_CR61","doi-asserted-by":"crossref","unstructured":"Shaikh S et al (2019) Mechanistic insights into the antimicrobial actions of metallic nanoparticles and their implications for multidrug resistance. Int J Mol Sci 20(10):2468","DOI":"10.3390\/ijms20102468"},{"issue":"1","key":"5118_CR206","first-page":"44","volume":"3","author":"A Shan","year":"2026","unstructured":"Shan A (2026) CRISPR-based antimicrobials: precision strategies against multidrug-resistant bacterial pathogens. Emerg Trends Med 3(1):44\u201355","journal-title":"Emerg Trends Med"},{"issue":"2","key":"5118_CR211","doi-asserted-by":"publisher","first-page":"e70168","DOI":"10.1002\/fft2.70168","volume":"7","author":"I Singh","year":"2026","unstructured":"Singh I et al (2026) Engineered probiotics: the next-generation therapeutics to combat antibiotic\u2010resistant bacterial infections. Food Front 7(2):e70168","journal-title":"Food Front"},{"issue":"7","key":"5118_CR93","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1038\/emboj.2011.41","volume":"30","author":"T Sinkunas","year":"2011","unstructured":"Sinkunas T et al (2011) Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR\/Cas immune system. Embo j 30(7):1335\u20131342","journal-title":"Embo j"},{"key":"5118_CR125","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jgar.2025.02.002","volume":"42","author":"HCA Souza","year":"2025","unstructured":"Souza HCA et al (2025) Unravelling the advances of CRISPR-Cas9 as a precise antimicrobial therapy: a systematic review. J Glob Antimicrob Resist 42:51\u201360","journal-title":"J Glob Antimicrob Resist"},{"issue":"1","key":"5118_CR223","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41467-018-08224-4","volume":"10","author":"J Strecker","year":"2019","unstructured":"Strecker J et al (2019) Engineering of CRISPR-Cas12b for human genome editing. Nat Commun 10(1):212","journal-title":"Nat Commun"},{"issue":"4","key":"5118_CR191","doi-asserted-by":"publisher","first-page":"01307","DOI":"10.1128\/jcm","volume":"57","author":"JR Strich","year":"2019","unstructured":"Strich JR, Chertow DS (2019) CRISPR-Cas biology and its application to infectious diseases. J Clin Microbiol 57(4):01307\u201301318. https:\/\/doi.org\/10.1128\/jcm","journal-title":"J Clin Microbiol"},{"key":"5118_CR189","doi-asserted-by":"crossref","unstructured":"S\u00fcnderhauf D et al (2019) AMR gene removal by conjugative delivery of CRISPR-Cas9. Access Microbiol 1(1A)","DOI":"10.1099\/acmi.ac2019.po0082"},{"key":"5118_CR214","doi-asserted-by":"publisher","first-page":"100983","DOI":"10.1016\/j.genrep.2020.100983","volume":"22","author":"AA Suleiman","year":"2021","unstructured":"Suleiman AA, Saedi WY, Muhaidi MJ (2021) Widely used gene editing strategies in cancer treatment a systematic review. Gene Rep 22:100983","journal-title":"Gene Rep"},{"key":"5118_CR183","doi-asserted-by":"crossref","unstructured":"Tagliaferri TL et al (2020) Exploring the potential of CRISPR-Cas9 under challenging conditions: facing high-copy plasmids and counteracting beta-lactam resistance in clinical strains of enterobacteriaceae. Front Microbiol 11","DOI":"10.3389\/fmicb.2020.00578"},{"key":"5118_CR138","doi-asserted-by":"publisher","first-page":"578","DOI":"10.3389\/fmicb.2020.00578","volume":"11","author":"TL Tagliaferri","year":"2020","unstructured":"Tagliaferri TL et al (2020) Exploring the potential of CRISPR-Cas9 under challenging conditions: facing high-copy plasmids and counteracting beta-lactam resistance in clinical strains of enterobacteriaceae. Front Microbiol 11:578","journal-title":"Front Microbiol"},{"key":"5118_CR106","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.2147\/IDR.S370869","volume":"15","author":"S Tao","year":"2022","unstructured":"Tao S et al (2022) The application of the CRISPR-Cas system in antibiotic resistance. Infect Drug Resist 15:4155\u20134168","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5118_CR157","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12866-023-03058-7","volume":"23","author":"S Tao","year":"2023","unstructured":"Tao S et al (2023) Elimination of blaKPC\u2009\u2013\u20092-mediated carbapenem resistance in Escherichia coli by CRISPR-Cas9 system. BMC Microbiol 23(1):310","journal-title":"BMC Microbiol"},{"issue":"10","key":"5118_CR33","doi-asserted-by":"publisher","first-page":"e0182225","DOI":"10.1128\/mbio.01822-25","volume":"16","author":"A Tarasenko","year":"2025","unstructured":"Tarasenko A et al (2025) Reprogramming resistance: phage-antibiotic synergy targets efflux systems in ESKAPEE pathogens. mBio 16(10):e0182225","journal-title":"mBio"},{"issue":"6","key":"5118_CR108","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s42452-026-08632-y","volume":"8","author":"ZH Teffera","year":"2026","unstructured":"Teffera ZH et al (2026) Contribution of CRISPR\/Cas9 technology in gene editing and its potential therapeutic benefits in combating antimicrobial-resistant bacteria: a narrative review. Discover Appl Sci 8(6):641","journal-title":"Discover Appl Sci"},{"key":"5118_CR49","doi-asserted-by":"publisher","first-page":"p8847267","DOI":"10.1155\/bmri\/8847267","volume":"2025","author":"AB Temesgen","year":"2025","unstructured":"Temesgen AB, Shiferaw SA (2025) Antimicrobial multidrug resistance and mechanisms of action: an overview. Biomed Res Int 2025:p8847267","journal-title":"Biomed Res Int"},{"issue":"18","key":"5118_CR46","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1016\/j.jmb.2019.04.002","volume":"431","author":"CL Tooke","year":"2019","unstructured":"Tooke CL et al (2019) \u03b2-Lactamases and \u03b2-Lactamase Inhibitors in the 21st Century. J Mol Biol 431(18):3472\u20133500","journal-title":"J Mol Biol"},{"issue":"5","key":"5118_CR218","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/nrg.2016.28","volume":"17","author":"SQ Tsai","year":"2016","unstructured":"Tsai SQ, Joung JK (2016) Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases. Nat Rev Genet 17(5):300\u2013312","journal-title":"Nat Rev Genet"},{"key":"5118_CR180","doi-asserted-by":"publisher","first-page":"1725247","DOI":"10.3389\/fmicb.2025.1725247","volume":"16","author":"PJ Tsolakidou","year":"2025","unstructured":"Tsolakidou PJ (2025) CRISPR-Cas systems against carbapenem resistance: from proof-of-concept to clinical translation. Front Microbiol 16:1725247","journal-title":"Front Microbiol"},{"issue":"3","key":"5118_CR219","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molcel.2016.07.004","volume":"63","author":"J Tycko","year":"2016","unstructured":"Tycko J, Myer VE, Hsu PD (2016) Methods for optimizing CRISPR-Cas9 genome editing specificity. Mol Cell 63(3):355\u2013370","journal-title":"Mol Cell"},{"issue":"12","key":"5118_CR66","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.jiph.2021.10.020","volume":"14","author":"TM Uddin","year":"2021","unstructured":"Uddin TM et al (2021) Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. J Infect Public Health 14(12):1750\u20131766","journal-title":"J Infect Public Health"},{"issue":"16","key":"5118_CR156","doi-asserted-by":"publisher","first-page":"9175","DOI":"10.3390\/ijms23169175","volume":"23","author":"HSM Walflor","year":"2022","unstructured":"Walflor HSM et al (2022) Resensitization of Fosfomycin-Resistant Escherichia coli Using the CRISPR System. Int J Mol Sci 23(16):9175","journal-title":"Int J Mol Sci"},{"key":"5118_CR118","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.2147\/IDR.S244885","volume":"13","author":"P Wan","year":"2020","unstructured":"Wan P et al (2020) Reversal of mcr-1-mediated colistin resistance in Escherichia coli by CRISPR-Cas9 system. Infect Drug Resist 13:1171\u20131178","journal-title":"Infect Drug Resist"},{"key":"5118_CR150","doi-asserted-by":"crossref","unstructured":"Wan F et al (2021) Novel strategy to combat antibiotic resistance: a sight into the combination of CRISPR\/Cas9 and nanoparticles. Pharmaceutics 13(3)","DOI":"10.3390\/pharmaceutics13030352"},{"issue":"8","key":"5118_CR133","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1093\/jac\/dkac166","volume":"77","author":"X Wan","year":"2022","unstructured":"Wan X et al (2022) Engineering a CRISPR interference system targeting AcrAB-TolC efflux pump to prevent multidrug resistance development in Escherichia coli. J Antimicrob Chemother 77(8):2158\u20132166","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"5118_CR104","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.str.2010.11.014","volume":"19","author":"R Wang","year":"2011","unstructured":"Wang R et al (2011) Interaction of the Cas6 riboendonuclease with CRISPR RNAs: recognition and cleavage. Structure 19(2):257\u2013264","journal-title":"Structure"},{"issue":"7","key":"5118_CR120","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1021\/acssynbio.6b00060","volume":"5","author":"Y Wang","year":"2016","unstructured":"Wang Y et al (2016) Bacterial genome editing with CRISPR-Cas9: deletion, integration, single nucleotide modification, and desirable clean mutant selection in clostridium beijerinckii as an example. ACS Synth Biol 5(7):721\u2013732","journal-title":"ACS Synth Biol"},{"issue":"1","key":"5118_CR161","doi-asserted-by":"publisher","first-page":"wrad039","DOI":"10.1093\/ismejo\/wrad039","volume":"18","author":"BNJ Watson","year":"2024","unstructured":"Watson BNJ et al (2024) CRISPR-Cas in Pseudomonas aeruginosa provides transient population-level immunity against high phage exposures. ISME J 18(1):wrad039","journal-title":"ISME J"},{"issue":"5","key":"5118_CR159","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1038\/s41396-020-00860-3","volume":"15","author":"RM Wheatley","year":"2020","unstructured":"Wheatley RM, MacLean RC (2020) CRISPR-Cas systems restrict horizontal gene transfer in Pseudomonas aeruginosa. ISME J 15(5):1420\u20131433","journal-title":"ISME J"},{"issue":"2","key":"5118_CR160","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/cr.2017.6","volume":"27","author":"B Wiedenheft","year":"2017","unstructured":"Wiedenheft B, Bondy-Denomy J (2017) CRISPR control of virulence in Pseudomonas aeruginosa. Cell Res 27(2):163\u2013164","journal-title":"Cell Res"},{"issue":"25","key":"5118_CR96","doi-asserted-by":"publisher","first-page":"10092","DOI":"10.1073\/pnas.1102716108","volume":"108","author":"B Wiedenheft","year":"2011","unstructured":"Wiedenheft B et al (2011) RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. Proc Natl Acad Sci U S A 108(25):10092\u201310097","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5118_CR113","doi-asserted-by":"publisher","first-page":"1747931","DOI":"10.3389\/fmicb.2026.1747931","volume":"17","author":"MSI Wizrah","year":"2026","unstructured":"Wizrah MSI (2026) CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges. Front Microbiol 17:1747931","journal-title":"Front Microbiol"},{"key":"5118_CR201","doi-asserted-by":"publisher","first-page":"1747931","DOI":"10.3389\/fmicb.2026.1747931","volume":"17","author":"MS Wizrah","year":"2026","unstructured":"Wizrah MS (2026) CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges. Front Microbiol 17:1747931","journal-title":"Front Microbiol"},{"key":"5118_CR75","doi-asserted-by":"crossref","unstructured":"Wizrah MSI (2026) CRISPR-Cas systems as next-generation antimicrobials: a systemic review of mechanisms, delivery strategies, and translational challenges. Front Microbiol 17:1747931","DOI":"10.3389\/fmicb.2026.1747931"},{"issue":"10","key":"5118_CR77","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1073\/pnas.1501698112","volume":"112","author":"AV Wright","year":"2015","unstructured":"Wright AV et al (2015) Rational design of a split-Cas9 enzyme complex. Proc Natl Acad Sci U S A 112(10):2984\u20132989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"5118_CR140","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1002\/bit.27143","volume":"116","author":"X Wu","year":"2019","unstructured":"Wu X et al (2019) Reducing Staphylococcus aureus resistance to lysostaphin using CRISPR-dCas9. Biotechnol Bioeng 116(12):3149\u20133159","journal-title":"Biotechnol Bioeng"},{"key":"5118_CR187","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jare.2019.01.011","volume":"18","author":"Z-Y Wu","year":"2019","unstructured":"Wu Z-Y et al (2019) Reversal of carbapenem-resistance in Shewanella algae by CRISPR\/Cas9 genome editing. J Adv Res 18:61\u201369","journal-title":"J Adv Res"},{"issue":"1","key":"5118_CR124","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12951-021-01132-8","volume":"19","author":"Y Wu","year":"2021","unstructured":"Wu Y et al (2021) Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. J Nanobiotechnol 19(1):401","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"5118_CR152","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/s12951-021-01132-8","volume":"19","author":"Y Wu","year":"2021","unstructured":"Wu Y et al (2021) Engineered CRISPR-Cas systems for the detection and control of antibiotic-resistant infections. J Nanobiotechnol 19(1):401","journal-title":"J Nanobiotechnol"},{"issue":"7522","key":"5118_CR240","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nature13589","volume":"514","author":"W Xue","year":"2014","unstructured":"Xue W et al (2014) CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 514(7522):380\u2013384","journal-title":"Nature"},{"key":"5118_CR212","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.virusres.2017.06.010","volume":"244","author":"HC Yang","year":"2018","unstructured":"Yang HC, Chen PJ (2018) The potential and challenges of CRISPR-Cas in eradication of hepatitis B virus covalently closed circular DNA. Virus Res 244:304\u2013310","journal-title":"Virus Res"},{"key":"5118_CR74","doi-asserted-by":"crossref","unstructured":"Yoon B, Kim JA, Kang YK (2026) CRISPR-Cas-mediated reprogramming strategies to overcome antimicrobial resistance. Pharmaceutics 18(1):95","DOI":"10.3390\/pharmaceutics18010095"},{"issue":"23","key":"5118_CR142","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1073\/pnas.1500107112","volume":"112","author":"I Yosef","year":"2015","unstructured":"Yosef I et al (2015) Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci U S A 112(23):7267\u20137272","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"5118_CR186","doi-asserted-by":"publisher","first-page":"7267","DOI":"10.1073\/pnas.1500107112","volume":"112","author":"I Yosef","year":"2015","unstructured":"Yosef I et al (2015) Temperate and lytic bacteriophages programmed to sensitize and kill antibiotic-resistant bacteria. Proc Natl Acad Sci 112(23):7267\u20137272","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"5118_CR246","first-page":"3","volume":"18","author":"M Yousefian","year":"2026","unstructured":"Yousefian M, Baharmast M (2026) Artificial intelligence-assisted CRISPR gene editing: current advances, clinical challenges, and future directions in precision medicine. Avicenna J Med Biotechnol 18(1):3","journal-title":"Avicenna J Med Biotechnol"},{"issue":"1","key":"5118_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/nyas.14134","volume":"1459","author":"HI Zgurskaya","year":"2020","unstructured":"Zgurskaya HI, Rybenkov VV (2020) Permeability barriers of Gram-negative pathogens. Ann N Y Acad Sci 1459(1):5\u201318","journal-title":"Ann N Y Acad Sci"},{"key":"5118_CR69","doi-asserted-by":"crossref","unstructured":"Zhang Z-L, Qian K-l, Xiao M-Z (2026) Global burden of lower respiratory infections associated with antimicrobial resistance: insights from the Global Burden of Disease. Antimicrob Resist Infection Control 15: 45","DOI":"10.1186\/s13756-026-01720-z"},{"issue":"3","key":"5118_CR103","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.molcel.2011.12.013","volume":"45","author":"J Zhang","year":"2012","unstructured":"Zhang J et al (2012) Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell 45(3):303\u2013313","journal-title":"Mol Cell"},{"issue":"4","key":"5118_CR155","doi-asserted-by":"publisher","first-page":"e03884","DOI":"10.1128\/spectrum.03884-23","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H et al (2024) Resensitizing tigecycline- and colistin-resistant\u2009Escherichia coli using an engineered conjugative CRISPR\/Cas9 system. Microbiol Spectr 12(4):e03884\u2013e03823","journal-title":"Microbiol Spectr"},{"issue":"4","key":"5118_CR247","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/microorganisms14040739","volume":"14","author":"E Zhang","year":"2026","unstructured":"Zhang E et al (2026) Application and research prospects of CRISPR\/Cas gene editing Technology in Lactic Acid Bacteria. Microorganisms 14(4):739","journal-title":"Microorganisms"},{"issue":"1","key":"5118_CR249","doi-asserted-by":"publisher","first-page":"dkaf442","DOI":"10.1093\/jac\/dkaf442","volume":"81","author":"R Zhao","year":"2026","unstructured":"Zhao R et al (2026) Harnessing CRISPR\u2013Cas9 and CRISPRi systems to reverse antibiotic resistance in a clinical multidrug-resistant Escherichia coli isolate. J Antimicrob Chemother 81(1):dkaf442","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5118_CR208","doi-asserted-by":"publisher","first-page":"2654259","DOI":"10.1080\/21505594.2026.2654259","volume":"17","author":"Z Zhou","year":"2026","unstructured":"Zhou Z et al (2026) Bacterial extracellular vesicles as emerging platforms to combat multidrug-resistant bacterial infections: mechanisms, therapeutic applications, and future prospects. Virulence 17(1):2654259","journal-title":"Virulence"},{"key":"5118_CR162","doi-asserted-by":"crossref","unstructured":"Zhu X-X et al (2024) Rapid detection of mexX in Pseudomonas aeruginosa based on CRISPR-Cas13a coupled with recombinase polymerase amplification. Front Microbiol 15:1341179","DOI":"10.3389\/fmicb.2024.1341179"},{"issue":"1","key":"5118_CR213","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.biotechadv.2016.12.003","volume":"35","author":"J Zischewski","year":"2017","unstructured":"Zischewski J, Fischer R, Bortesi L (2017) Detection of on-target and off-target mutations generated by CRISPR\/Cas9 and other sequence-specific nucleases. Biotechnol Adv 35(1):95\u2013104","journal-title":"Biotechnol Adv"},{"issue":"1","key":"5118_CR148","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13099-026-00800-0","volume":"18","author":"A Zubair","year":"2026","unstructured":"Zubair A et al (2026) Gut microbiome-based strategies for HIV prevention and therapy, current challenges and future prospects. Gut Pathogens 18(1):11","journal-title":"Gut Pathogens"},{"issue":"1","key":"5118_CR205","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s11671-026-04722-3","volume":"21","author":"A Zubair","year":"2026","unstructured":"Zubair A et al (2026) Nanotechnology revolutionizing antimicrobial therapy for superbug infections. Discover Nano 21(1):275","journal-title":"Discover Nano"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05118-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-026-05118-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:04:27Z","timestamp":1793030667000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-026-05118-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":253,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["5118"],"URL":"https:\/\/doi.org\/10.1007\/s00203-026-05118-8","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"22 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No applicable.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research does not include any human or animal subjects.","order":3,"name":"Ethics","label":"Human or animal research","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":5,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"530"}}